Related Experiment Video
Updated: Jun 13, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
[Long-term results of patients with congenital diaphragmatic hernia]
C Menéndez1, M Fariñas, A Parente
1Servicio Neonatología, Hospital Infantil Gregorio Marañón, Madrid.
Insights
Long-term survivors of congenital diaphragmatic hernia (CDH) show good development and quality of life, with low comorbidity. Most children experience mild issues, with only 5% having serious sequels.
Area of Science:
- Pediatric Surgery
- Neonatal Care
- Congenital Malformations
Context:
- Congenital diaphragmatic hernia (CDH) survival rates have improved due to advanced therapies.
- Long-term outcomes for CDH survivors are not well-documented.
- This study analyzes the long-term clinical evolution of CDH patients.
Purpose:
- To evaluate the long-term respiratory, cardiological, digestive, and neurological outcomes in CDH survivors.
- To assess the overall comorbidity and quality of life in children treated for CDH.
Summary:
- Forty CDH survivors (mean age 4.2 years) were assessed via medical records and parental interviews.
- Respiratory issues (22%) and gastroesophageal reflux (47%) were most common, with few requiring intervention.
- Serious long-term sequels were observed in only 5% of patients, indicating a favorable prognosis.
Impact:
- Provides crucial data on the long-term health of CDH survivors.
- Highlights the generally good quality of life and low comorbidity in this population.
- Informs future management strategies and parental counseling for congenital diaphragmatic hernia.
Objective:
Introduction of advanced therapeutic modalities for diaphragmatic congenital hernia (CDH) has allowed to reach considerable improvements in survival rate. Nevertheless, there are few studies which analyze the clinical evolution of the long-term survivors. The aim of this work is to analyze the outcomes of the patients with CDH in our hospital.
Methods:
Fifty-five neonates with CDH were treated in our center between 1998 and 2005. We included in the study those patients that were alive at the moment of first hospital discharge (72%; n=40 patients). ECMO therapy was needed in 6 of them during neonatal treatment. A descriptive transverse review of the clinical record as well as a telephonic interview to the parents was performed for the respiratory, cardiological, digestive and neurological conditions, following standard diagnostic studies in every case. The mean age of the children in the moment of the study was 4.2 years (1-9).
Results:
The 8.3% of the children needed domiciliary oxygen therapy during a maximum of 3 months in all the cases. 22% of the cases suffered from respiratory problems, being bronchiolitis and pneumonia the most frequent diagnoses. Only a patient developed asthma. The gastroesophageal reflux is the most frequent long-term condition (47%), but only 8.3% needs surgical treatment. Regarding to cardiological problems, 14% developed pulmonary hypertension, being slight - moderate in all the cases but in one case who was the only deceased of the series. Regarding to neurological problems only 1 patient developed serious alterations (brain paralysis), having suffered a hemorrhage parenquimatosa during the treatment with ECMO. No other patient presents motor, visual nor auditory alterations in the development, last mild alteration in language (4 patients). Differences do not exist with the group of patients that did not need ECMO during the treatment in cardiological and digestive complications, being higher percentage with respiratory problems.
Conclusion:
In our sample only 2 patients present serious sequels (5%). Of this preliminary study we can conclude that the comorbility in the CDH is very low having these patient a good development and good quality of life.
Related Concept Videos
Hiatal Hernia
Pneumothorax-II
Clinical Manifestations:
Pulmonary Cycle: Exhalation
